肾素-血管紧张素系统与心房颤动关系的研究进展

www.yongyao.net　　2009-9-29 13:49:16　　来源：　　责任编辑：

分享到：

[ 参考文献]
[ 1 ] 　Nakashima H, Kumagai K,Urata H, et al. Angiotensin II antagonist p revents electrical remodelling in atrial fibrillation[ J ]. Circulation, 2000, 101: 2612-2617.
[ 2 ] 　Goette A, Staack T, Rocken C, et al. Increased exp ression of extracellular signalregulated kinase and angiotensin2converting enzyme in human atria during atrial fibrillation[ J ]. J Am Coll Cardiol, 2000, 35: 1669-1677.
[ 3 ] 　Pedersen OD,Bagger H, K? ber L, et al. Trandolap ril reduces the incidence of atrial fibrillation after acute myocardial infarction in patientswith left ventricular dysfunction[ J ]. Circulation, 1999, 100: 376-380.
[ 4 ] 　Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II recep tor blockade reduces newonset atrial fibrillation and subsequent stroke compared to atenolol: TheLosartan Intervention For End Point Reduction in Hypertension (L IFE) Study[ J ]. J Am Coll Cardiol, 2005, 45: 712-719.
[ 5 ] 　Murray KT, Rottman JN,Arbogast PG, et al. Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFF IRM [ J ]. Heart Rhythm, 2004, 1 (6) :669-675.
[ 6 ] 　Kistler PM,Davidson NC, Sanders P, et al. Absence of acute effects of angiotensin II on atrial electrophysiology in humans [ J ]. J Am Coll Cardiol, 2005, 45:154-156.
[ 7 ] 　Booz GW,Baker KW. Molecular signalingmechanisms controlling growth and function of cardiac fibroblasts[ J ]. Cardiovasc Res, 1995, 30 (4) : 537-543.
[ 8 ] 　BoldtA,WetzelU,Lauschke J , et al. Fibrosis in left atrial tissue of patientswith atrial fibrillation with and without underlying mitral valve disease [ J ]. Heart,2004, 90: 400-405.
[ 9 ] 　Cardin S,L iD, Thorin2TrescasesN, et al. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin2dependent andindependent pathways[ J ]. Cardiovasc Res, 2003, 60: 315-325.
[ 10 ] 　L iD, Fareh S,Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort[ J ]. Circulation, 1999, 100: 87-95.
[ 11 ] 　L iD, Shinagawa K, PangL, et al. Effects of angiotensin2converting enzyme inhibition on the development of the atrial fibrillation substrate in dogswith ventricular tachypacing2induced congestive heart failure [ J ]. Circulation, 2001, 104:2608-2614.
[ 12 ] 　Goette A,A rndtM, Rocken C, et al. Regulation of angiotensin II recep tor subtypes during atrial fibrillation in humans [ J ]. Circulation, 2000, 101: 2678-2681.
[ 13 ] 　BoldtA,WetzelU,Weigl J , et al. Exp ression of angiotensin II recep tors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease[ J ]. J Am Coll Cardiol, 2003, 42: 1785-1792.
[ 14 ] 　Vermes E, Tardif JC,Bourassa MG, et al. Enalap ril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction [ J ]. Circulation,2003, 107 (23) : 2926-2931.
[ 15 ] 　L′Allier PL,Ducharme A, Keller PF, et al. Angiotensin2converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation[ J ]. J Am Coll Cardiol, 2004, 44: 159-164.
[ 16 ] 　MaggioniAP,Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val2HeFT) [ J ]. Am Heart J , 2005, 149: 548-557.
[ 17 ] 　Swedberg K, PfefferM, Cohen2Solal A, et al. Prevention of atrial fibrillation in symp tomatic chronic heart failure by candesartan: results from CHARM ( abstract) [ J ]. J Am Coll Cardiol, 2004, 43 ( supp l. 1) :A222.
[ 18 ] 　Madrid AH, Bueno MG, Jose MG, et al. Use of irbesartan to maintain sinus rhythm in patientswith long2lasting persistent atrial fibrillation[ J ]. Circulation,2002, 106: 331.
[ 19 ] 　Madrid AH, Peng J , Zamora J , et al. The role of angiotensin recep tor blockers and /or angiotensin converting enzyme inhibitors in the p revention of atrial fibrillation in patients with cardiovascular diseases: meta2analysis of randomized controlled clinical trials[ J ]. Pacing Clin Electrophysiol, 2004, 27 ( 10) : 1405-1410.
[ 20 ] 　Anand K,MoossAN, Hee TT, et al. Meta2analysis: inhibition of renin2angiotensin system p revents new2onset atrial fibrillation [ J ]. Am Heart J , 2006, 152(2) : 217-222.
[ 21 ] 　Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin2converting enzyme inhibitors and angiotensin recep tor blockers: ameta2analysis[ J ]. J Am Coll Cardiol, 2005, 45 (11) : 1832-1839.
[ 22 ] 　DostalDE. Regulation of cardiac collagen: angiotensin and cross2talk with local growth factors[ J ]. Hypertension, 2001, 37: 841-844.